Results 211 to 220 of about 1,197,543 (390)

Anemia and growth

Indian Journal of Endocrinology and Metabolism, 2014
Ashraf T Soliman, Vincenzo De Sanctis, Sanjay Kalra   +2 more
openaire   +4 more sources

Confirmation of Fixed Quarterly Riliprubart Regimen in Patients with Cold Agglutinin Disease Using Population PK/PD and Exposure‐Response Analyses

Clinical Pharmacology &Therapeutics, EarlyView.
Riliprubart is a second‐generation, humanized immunoglobulin G4 that inhibits only the activated form of the C1s component of the proximal classical complement pathway. The clinical studies of riliprubart conducted thus far for the treatment of cold agglutinin disease (CAD), a rare autoimmune disease, include a Phase 1 first‐in‐human study in healthy ...
Timothy Chow, Marek Wardecki, Michael Storek, Nancy Wong   +3 more
wiley   +1 more source

Nutritional Assessment of Infants with Hypochromic Anemia

, 1959
Calvin W. Woodruff, MARTHA DAILY GOODE
openalex   +1 more source

The Treatment of Iron Deficiency Anemia [PDF]

, 1955
Daniel H. Coleman, A.R. Stevens, Clement A. Finch   +2 more
openalex   +1 more source

Use of PopPK and E‐R Analyses toward Explaining Causal Link Between ADAMTS13 in Recombinant vs. Plasma‐Based Therapies and Clinical Effects in cTTP

Clinical Pharmacology &Therapeutics, EarlyView.
Congenital thrombotic thrombocytopenic purpura (cTTP) is an ultra‐rare, potentially life‐threatening condition caused by a deficiency of the blood enzyme ADAMTS13. Until now, ADAMTS13 replacement has been achieved with infusions of plasma or plasma‐based therapies (PBT).
Munjal Patel, Huijuan Xu, Olivier Barriere, Paul Diderichsen, Parth Patwari, Andy Z. X. Zhu, Jean François Marier, Thomas Peyret, Linda T. Wang, Björn Mellgård, Wenping Wang, Indranil Bhattacharya   +11 more
wiley   +1 more source

Studies on Anemia of Disseminated Malignant Neoplastic Disease [PDF]

, 1954
George A. Hyman, Jane L. Harvey
openalex   +1 more source

Folinic Acid Prophylaxis and Dose Adjustments Enable Safe Treatment with Pemetrexed in Patients with Renal Impairment

Clinical Pharmacology &Therapeutics, EarlyView.
Pemetrexed is a cornerstone in chemo(immunotherapy) of non‐small cell lung cancer and mesothelioma; however, it is contraindicated in patients with renal impairment due to severe toxicity concerns. Therefore, a large proportion of patients is withheld from effective chemo(immunotherapy).
Nikki de Rouw, Leila‐Sophie Otten, Mart P. Kicken, Berber Piet, Bonne Biesma, Bianca van Veggel, Christi M.J. Steendam, Ben van den Borne, Lizza E.L. Hendriks, Sander Croes, Anne‐Marie C. Dingemans, Daphne W. Dumoulin, Ron H.J. Mathijssen, Jacobus A. Burgers, Alwin D.R. Huitema, Hieronymus J. Derijks, Maarten J. Deenen, Michel M. van den Heuvel, Rob ter Heine   +18 more
wiley   +1 more source

Mapping anemia prevalence across Indonesia. [PDF]

Asia Pac J Clin Nutr
Priliani L, Harahap AR, Satyagraha AW, Noviyanti R, Apriyana I, Nanine I, Sudoyo H, Malik SG.   +7 more
europepmc   +1 more source

THE ANEMIA OF INFECTION. XIII. STUDIES ON EXPERI-MENTALLY PRODUCED ACUTE HYPOFERREMIA IN DOGS AND THE RELATIONSHIP OF THE ADRENAL CORTEX TO HYPOFERREMIA 1 [PDF]

, 1951
G. E. Cartwright, D. Lee Hamilton, Clark J. Gubler, N. M. Fellows, Helen Ashenbrucker, M. M. Wintrobe   +5 more
openalex   +1 more source

Frequency and stability of populations of CD4+ and CD4+CD25+Foxp3+CD127lo Treg in healthy adults defined by cytometry using monoclonal antibodies to T cell associated molecules

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Monitoring subpopulations of CD4+ T cells in blood, especially regulatory CD4+CD25+Foxp3+CD127loT cells, has the potential to identify tolerance to transplants and defects that cause autoimmunity. CD45RA is expressed by naïve/resting CD4+, not by activated cells.
Nirupama D. Verma, Ranje Al‐atiyah, Prateek Rakesh, Andrew D. Lam, Christopher Chiu, Giang T. Tran, Bruce M. Hall, Suzanne J. Hodgkinson   +7 more
wiley   +1 more source